UNSPSC 51282608: Cefepime dihydrochloride

This classification denotes a cephalosporin antibiotic with the molecular formula C19H24N6O5S2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2A1O4F5N0C, chemically known as (6r,7r)-7-(((2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl)amino)-3-((1-methylpyrrolidin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid chloride hydrochloride, but more generally known as cefepime dihydrochloride, which bears US NIH Compound Identifier 9571075.

European Medicines Agency schedules cefepime dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07390MIG. Most nations, for tariff purposes, schedule cefepime dihydrochloride under HS 29419000. SMILES: C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4CSC(N4)N)SC2)C(=O)[O-].CL.CL.

UNSPSC 51282608 Cefepime dihydrochloride, a Commodity code, shows minimal relevant recent activity in state and local procurement. The recent opportunities tagged to this code span naloxone distribution, fire department medical supplies, and multi-state pharmaceutical cooperative purchasing — none of which are cefepime or cephalosporin-class antibiotics. The mismatch suggests that state and local procurement systems are either applying this code incorrectly to broader pharmaceutical and medical-supply categories, or that cefepime itself draws no identifiable recent solicitation activity at the state and local level. The concrete work being procured under related pharmaceutical codes includes emergency-response medications (naloxone), first-aid consumables for fire departments, and generic multi-source drugs through cooperative purchasing arrangements, but cefepime is not named in any of the recent opportunities.

The issuing bodies across recent pharmaceutical and medical-supply solicitations include county health departments (Seminole County, Florida), city fire departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving Minnesota and Oregon). Activity is concentrated in Florida, Texas, and the Upper Midwest, with Texas HHS exploring direct-to-manufacturer contracting models and MMCAP managing multi-vendor generic-drug arrangements across state and local health systems. The City of Tampa's IFB for fire-rescue medical supplies (26P00145, due March 13, 2026, estimated $700,000) and MMCAP's RFP for generic pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) are the most recent concrete opportunities, but neither addresses cefepime specifically. If pursuing this code, verify whether cefepime is listed under state or local hospital formularies or emergency-response procurement before committing business-development resources; the code itself shows no sustained or identifiable state-local market.